Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Research shows nearly half of people with type 2 diabetes stop taking GLP-1 drugs within a year due to factors like cost and side effects
This section is dense but essential
In the SURPASS and SURMOUNT trials, Lilly has so far compared tirzepatide to older treatments or placebo (for T2D and obesity)
Im saying it because Ive watched patients waste hundreds of dollars on products that never had a chance of working while their health continued to decline
Free text responses indicated participants experienced some trepidation before their interviews but had a positive experience overall and valued the professionalism/supportiveness of the study team and the opportunity to use their experience/insights to contribute to research
US$ 25.00
US$ 26.60
US$ 27.77
US$ 21.53
US$ 21.78
US$ 22.73
US$ 27.11
